Global Drug-Coated Balloon for Peripheral Artery Diseases Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels.
LPI (LP Information)' newest research report, the “Drug-Coated Balloon for Peripheral Artery Diseases Industry Forecast” looks at past sales and reviews total world Drug-Coated Balloon for Peripheral Artery Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug-Coated Balloon for Peripheral Artery Diseases sales for 2023 through 2029. With Drug-Coated Balloon for Peripheral Artery Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Coated Balloon for Peripheral Artery Diseases industry.
This Insight Report provides a comprehensive analysis of the global Drug-Coated Balloon for Peripheral Artery Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Coated Balloon for Peripheral Artery Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug-Coated Balloon for Peripheral Artery Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Coated Balloon for Peripheral Artery Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Coated Balloon for Peripheral Artery Diseases.
The global Drug-Coated Balloon for Peripheral Artery Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug-Coated Balloon for Peripheral Artery Diseases players cover Medtronic, Boston Scientific, BD, Philips and Aachen Resonance, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Coated Balloon for Peripheral Artery Diseases market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Drug-Coated Balloon for Peripheral Artery Diseases market?
What factors are driving Drug-Coated Balloon for Peripheral Artery Diseases market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Coated Balloon for Peripheral Artery Diseases market opportunities vary by end market size?
How does Drug-Coated Balloon for Peripheral Artery Diseases break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels.
LPI (LP Information)' newest research report, the “Drug-Coated Balloon for Peripheral Artery Diseases Industry Forecast” looks at past sales and reviews total world Drug-Coated Balloon for Peripheral Artery Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug-Coated Balloon for Peripheral Artery Diseases sales for 2023 through 2029. With Drug-Coated Balloon for Peripheral Artery Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Coated Balloon for Peripheral Artery Diseases industry.
This Insight Report provides a comprehensive analysis of the global Drug-Coated Balloon for Peripheral Artery Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Coated Balloon for Peripheral Artery Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug-Coated Balloon for Peripheral Artery Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Coated Balloon for Peripheral Artery Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Coated Balloon for Peripheral Artery Diseases.
The global Drug-Coated Balloon for Peripheral Artery Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug-Coated Balloon for Peripheral Artery Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug-Coated Balloon for Peripheral Artery Diseases players cover Medtronic, Boston Scientific, BD, Philips and Aachen Resonance, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Coated Balloon for Peripheral Artery Diseases market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Paclitaxel Coated
- Other Coated
- Hospitals
- ASCs
- Catheterization Laboratory
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific
- BD
- Philips
- Aachen Resonance
What is the 10-year outlook for the global Drug-Coated Balloon for Peripheral Artery Diseases market?
What factors are driving Drug-Coated Balloon for Peripheral Artery Diseases market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Coated Balloon for Peripheral Artery Diseases market opportunities vary by end market size?
How does Drug-Coated Balloon for Peripheral Artery Diseases break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug-Coated Balloon for Peripheral Artery Diseases by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug-Coated Balloon for Peripheral Artery Diseases by Country/Region, 2018, 2022 & 2029
2.2 Drug-Coated Balloon for Peripheral Artery Diseases Segment by Type
2.2.1 Paclitaxel Coated
2.2.2 Other Coated
2.3 Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
2.3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
2.3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Type (2018-2023)
2.4 Drug-Coated Balloon for Peripheral Artery Diseases Segment by Application
2.4.1 Hospitals
2.4.2 ASCs
2.4.3 Catheterization Laboratory
2.5 Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
2.5.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Market Share by Application (2018-2023)
2.5.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Application (2018-2023)
3 GLOBAL DRUG-COATED BALLOON FOR PERIPHERAL ARTERY DISEASES BY COMPANY
3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Breakdown Data by Company
3.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales by Company (2018-2023)
3.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Company (2018-2023)
3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Revenue by Company (2018-2023)
3.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Company (2018-2023)
3.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Company (2018-2023)
3.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Company
3.4 Key Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Product Location Distribution
3.4.2 Players Drug-Coated Balloon for Peripheral Artery Diseases Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-COATED BALLOON FOR PERIPHERAL ARTERY DISEASES BY GEOGRAPHIC REGION
4.1 World Historic Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country/Region (2018-2023)
4.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth
4.4 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth
4.5 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth
4.6 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth
5 AMERICAS
5.1 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country
5.1.1 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023)
5.1.2 Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023)
5.2 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
5.3 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region
6.1.1 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2018-2023)
6.1.2 APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2018-2023)
6.2 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
6.3 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases by Country
7.1.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023)
7.1.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023)
7.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
7.3 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases by Country
8.1.1 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
8.3 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Coated Balloon for Peripheral Artery Diseases
10.3 Manufacturing Process Analysis of Drug-Coated Balloon for Peripheral Artery Diseases
10.4 Industry Chain Structure of Drug-Coated Balloon for Peripheral Artery Diseases
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Coated Balloon for Peripheral Artery Diseases Distributors
11.3 Drug-Coated Balloon for Peripheral Artery Diseases Customer
12 WORLD FORECAST REVIEW FOR DRUG-COATED BALLOON FOR PERIPHERAL ARTERY DISEASES BY GEOGRAPHIC REGION
12.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Forecast by Region
12.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecast by Region (2024-2029)
12.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecast by Type
12.7 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.1.3 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.2.3 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.3.3 BD Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Philips
13.4.1 Philips Company Information
13.4.2 Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.4.3 Philips Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Philips Main Business Overview
13.4.5 Philips Latest Developments
13.5 Aachen Resonance
13.5.1 Aachen Resonance Company Information
13.5.2 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.5.3 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Aachen Resonance Main Business Overview
13.5.5 Aachen Resonance Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug-Coated Balloon for Peripheral Artery Diseases by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug-Coated Balloon for Peripheral Artery Diseases by Country/Region, 2018, 2022 & 2029
2.2 Drug-Coated Balloon for Peripheral Artery Diseases Segment by Type
2.2.1 Paclitaxel Coated
2.2.2 Other Coated
2.3 Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
2.3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
2.3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Type (2018-2023)
2.4 Drug-Coated Balloon for Peripheral Artery Diseases Segment by Application
2.4.1 Hospitals
2.4.2 ASCs
2.4.3 Catheterization Laboratory
2.5 Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
2.5.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Market Share by Application (2018-2023)
2.5.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Application (2018-2023)
3 GLOBAL DRUG-COATED BALLOON FOR PERIPHERAL ARTERY DISEASES BY COMPANY
3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Breakdown Data by Company
3.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales by Company (2018-2023)
3.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Company (2018-2023)
3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Revenue by Company (2018-2023)
3.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Company (2018-2023)
3.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Company (2018-2023)
3.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Company
3.4 Key Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Product Location Distribution
3.4.2 Players Drug-Coated Balloon for Peripheral Artery Diseases Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-COATED BALLOON FOR PERIPHERAL ARTERY DISEASES BY GEOGRAPHIC REGION
4.1 World Historic Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country/Region (2018-2023)
4.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth
4.4 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth
4.5 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth
4.6 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth
5 AMERICAS
5.1 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country
5.1.1 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023)
5.1.2 Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023)
5.2 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
5.3 Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region
6.1.1 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2018-2023)
6.1.2 APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2018-2023)
6.2 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
6.3 APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases by Country
7.1.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023)
7.1.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023)
7.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
7.3 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases by Country
8.1.1 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type
8.3 Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Coated Balloon for Peripheral Artery Diseases
10.3 Manufacturing Process Analysis of Drug-Coated Balloon for Peripheral Artery Diseases
10.4 Industry Chain Structure of Drug-Coated Balloon for Peripheral Artery Diseases
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Coated Balloon for Peripheral Artery Diseases Distributors
11.3 Drug-Coated Balloon for Peripheral Artery Diseases Customer
12 WORLD FORECAST REVIEW FOR DRUG-COATED BALLOON FOR PERIPHERAL ARTERY DISEASES BY GEOGRAPHIC REGION
12.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Forecast by Region
12.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecast by Region (2024-2029)
12.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecast by Type
12.7 Global Drug-Coated Balloon for Peripheral Artery Diseases Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.1.3 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.2.3 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.3.3 BD Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Philips
13.4.1 Philips Company Information
13.4.2 Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.4.3 Philips Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Philips Main Business Overview
13.4.5 Philips Latest Developments
13.5 Aachen Resonance
13.5.1 Aachen Resonance Company Information
13.5.2 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
13.5.3 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Aachen Resonance Main Business Overview
13.5.5 Aachen Resonance Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Paclitaxel Coated
Table 4. Major Players of Other Coated
Table 5. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 6. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Table 7. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2018-2023) & ($ million)
Table 8. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Type (2018-2023)
Table 9. Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 11. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Table 12. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2018-2023)
Table 13. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Application (2018-2023)
Table 14. Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Company (2018-2023) & (Units)
Table 16. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Company (2018-2023)
Table 17. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Company (2018-2023)
Table 19. Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Producing Area Distribution and Sales Area
Table 21. Players Drug-Coated Balloon for Peripheral Artery Diseases Products Offered
Table 22. Drug-Coated Balloon for Peripheral Artery Diseases Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share Geographic Region (2018-2023)
Table 27. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country/Region (2018-2023)
Table 31. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023) & (Units)
Table 34. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2018-2023)
Table 35. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2018-2023)
Table 37. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 38. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 39. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2018-2023) & (Units)
Table 40. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region (2018-2023)
Table 41. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Region (2018-2023)
Table 43. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 44. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 45. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023) & (Units)
Table 46. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2018-2023)
Table 47. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2018-2023)
Table 49. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 50. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Drug-Coated Balloon for Peripheral Artery Diseases
Table 58. Key Market Challenges & Risks of Drug-Coated Balloon for Peripheral Artery Diseases
Table 59. Key Industry Trends of Drug-Coated Balloon for Peripheral Artery Diseases
Table 60. Drug-Coated Balloon for Peripheral Artery Diseases Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Drug-Coated Balloon for Peripheral Artery Diseases Distributors List
Table 63. Drug-Coated Balloon for Peripheral Artery Diseases Customer List
Table 64. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 80. Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Boston Scientific Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 84. Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 85. Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Boston Scientific Main Business
Table 87. Boston Scientific Latest Developments
Table 88. BD Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 89. BD Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 90. BD Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. BD Main Business
Table 92. BD Latest Developments
Table 93. Philips Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 94. Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 95. Philips Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Philips Main Business
Table 97. Philips Latest Developments
Table 98. Aachen Resonance Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 99. Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 100. Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Aachen Resonance Main Business
Table 102. Aachen Resonance Latest Developments
Table 1. Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug-Coated Balloon for Peripheral Artery Diseases Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Paclitaxel Coated
Table 4. Major Players of Other Coated
Table 5. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 6. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Table 7. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2018-2023) & ($ million)
Table 8. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Type (2018-2023)
Table 9. Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 11. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Table 12. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2018-2023)
Table 13. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Application (2018-2023)
Table 14. Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Company (2018-2023) & (Units)
Table 16. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Company (2018-2023)
Table 17. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Company (2018-2023)
Table 19. Global Drug-Coated Balloon for Peripheral Artery Diseases Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Producing Area Distribution and Sales Area
Table 21. Players Drug-Coated Balloon for Peripheral Artery Diseases Products Offered
Table 22. Drug-Coated Balloon for Peripheral Artery Diseases Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share Geographic Region (2018-2023)
Table 27. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country/Region (2018-2023)
Table 31. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023) & (Units)
Table 34. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2018-2023)
Table 35. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2018-2023)
Table 37. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 38. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 39. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2018-2023) & (Units)
Table 40. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region (2018-2023)
Table 41. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Region (2018-2023)
Table 43. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 44. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 45. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023) & (Units)
Table 46. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2018-2023)
Table 47. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2018-2023)
Table 49. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 50. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Drug-Coated Balloon for Peripheral Artery Diseases
Table 58. Key Market Challenges & Risks of Drug-Coated Balloon for Peripheral Artery Diseases
Table 59. Key Industry Trends of Drug-Coated Balloon for Peripheral Artery Diseases
Table 60. Drug-Coated Balloon for Peripheral Artery Diseases Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Drug-Coated Balloon for Peripheral Artery Diseases Distributors List
Table 63. Drug-Coated Balloon for Peripheral Artery Diseases Customer List
Table 64. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 80. Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Boston Scientific Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 84. Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 85. Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Boston Scientific Main Business
Table 87. Boston Scientific Latest Developments
Table 88. BD Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 89. BD Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 90. BD Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. BD Main Business
Table 92. BD Latest Developments
Table 93. Philips Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 94. Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 95. Philips Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Philips Main Business
Table 97. Philips Latest Developments
Table 98. Aachen Resonance Basic Information, Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Base, Sales Area and Its Competitors
Table 99. Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolios and Specifications
Table 100. Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Aachen Resonance Main Business
Table 102. Aachen Resonance Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug-Coated Balloon for Peripheral Artery Diseases
Figure 2. Drug-Coated Balloon for Peripheral Artery Diseases Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Paclitaxel Coated
Figure 10. Product Picture of Other Coated
Figure 11. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type in 2022
Figure 12. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Type (2018-2023)
Figure 13. Drug-Coated Balloon for Peripheral Artery Diseases Consumed in Hospitals
Figure 14. Global Drug-Coated Balloon for Peripheral Artery Diseases Market: Hospitals (2018-2023) & (Units)
Figure 15. Drug-Coated Balloon for Peripheral Artery Diseases Consumed in ASCs
Figure 16. Global Drug-Coated Balloon for Peripheral Artery Diseases Market: ASCs (2018-2023) & (Units)
Figure 17. Drug-Coated Balloon for Peripheral Artery Diseases Consumed in Catheterization Laboratory
Figure 18. Global Drug-Coated Balloon for Peripheral Artery Diseases Market: Catheterization Laboratory (2018-2023) & (Units)
Figure 19. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2022)
Figure 20. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Application in 2022
Figure 21. Drug-Coated Balloon for Peripheral Artery Diseases Sales Market by Company in 2022 (Units)
Figure 22. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Company in 2022
Figure 23. Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Company in 2022
Figure 25. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales 2018-2023 (Units)
Figure 28. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2018-2023 ($ Millions)
Figure 29. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales 2018-2023 (Units)
Figure 30. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2018-2023 ($ Millions)
Figure 31. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales 2018-2023 (Units)
Figure 32. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales 2018-2023 (Units)
Figure 34. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2018-2023 ($ Millions)
Figure 35. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country in 2022
Figure 36. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country in 2022
Figure 37. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Figure 38. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Figure 39. United States Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region in 2022
Figure 44. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Regions in 2022
Figure 45. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Figure 46. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Figure 47. China Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country in 2022
Figure 55. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country in 2022
Figure 56. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Figure 57. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Figure 58. Germany Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Figure 67. Egypt Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Drug-Coated Balloon for Peripheral Artery Diseases in 2022
Figure 73. Manufacturing Process Analysis of Drug-Coated Balloon for Peripheral Artery Diseases
Figure 74. Industry Chain Structure of Drug-Coated Balloon for Peripheral Artery Diseases
Figure 75. Channels of Distribution
Figure 76. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Forecast by Region (2024-2029)
Figure 77. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Drug-Coated Balloon for Peripheral Artery Diseases
Figure 2. Drug-Coated Balloon for Peripheral Artery Diseases Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Paclitaxel Coated
Figure 10. Product Picture of Other Coated
Figure 11. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type in 2022
Figure 12. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Type (2018-2023)
Figure 13. Drug-Coated Balloon for Peripheral Artery Diseases Consumed in Hospitals
Figure 14. Global Drug-Coated Balloon for Peripheral Artery Diseases Market: Hospitals (2018-2023) & (Units)
Figure 15. Drug-Coated Balloon for Peripheral Artery Diseases Consumed in ASCs
Figure 16. Global Drug-Coated Balloon for Peripheral Artery Diseases Market: ASCs (2018-2023) & (Units)
Figure 17. Drug-Coated Balloon for Peripheral Artery Diseases Consumed in Catheterization Laboratory
Figure 18. Global Drug-Coated Balloon for Peripheral Artery Diseases Market: Catheterization Laboratory (2018-2023) & (Units)
Figure 19. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2022)
Figure 20. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Application in 2022
Figure 21. Drug-Coated Balloon for Peripheral Artery Diseases Sales Market by Company in 2022 (Units)
Figure 22. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Company in 2022
Figure 23. Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Company in 2022
Figure 25. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales 2018-2023 (Units)
Figure 28. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2018-2023 ($ Millions)
Figure 29. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales 2018-2023 (Units)
Figure 30. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2018-2023 ($ Millions)
Figure 31. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales 2018-2023 (Units)
Figure 32. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales 2018-2023 (Units)
Figure 34. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2018-2023 ($ Millions)
Figure 35. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country in 2022
Figure 36. Americas Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country in 2022
Figure 37. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Figure 38. Americas Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Figure 39. United States Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region in 2022
Figure 44. APAC Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Regions in 2022
Figure 45. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Figure 46. APAC Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Figure 47. China Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country in 2022
Figure 55. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country in 2022
Figure 56. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Figure 57. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Figure 58. Germany Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2018-2023)
Figure 67. Egypt Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Drug-Coated Balloon for Peripheral Artery Diseases in 2022
Figure 73. Manufacturing Process Analysis of Drug-Coated Balloon for Peripheral Artery Diseases
Figure 74. Industry Chain Structure of Drug-Coated Balloon for Peripheral Artery Diseases
Figure 75. Channels of Distribution
Figure 76. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Forecast by Region (2024-2029)
Figure 77. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share Forecast by Application (2024-2029)
